ロード中...
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance
Despite significant advances in the treatment of hepatitis C virus (HCV) infection, the need to develop preventative vaccines remains. Identification of the best vaccine candidates and evaluation of their performance in preclinical and clinical development will require appropriate neutralization ass...
保存先:
| 出版年: | J Virol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4794667/ https://ncbi.nlm.nih.gov/pubmed/26699643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02700-15 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|